Authorized company
ROCHEM BIOCARE COLOMBIA S.A.S.
ROCHEM BIOCARE COLOMBIA S.A.S.
Colombia INVIMA·789 registered devices·Dec 20, 2021 – Jun 11, 2034
789
Total devices
5
Risk classes
2021
Earliest
2034
Latest
Recent registrations
Latest 20 INVIMA device registrations
STAT-NAT® HSV-2
STAT-NAT® HSV-2
4ce7aa62a988cd12031683b0ae7f5ad7
III
STAT-NAT® CMV
STAT-NAT® CMV
2780f09271ad39af25f234a7a2e43c31
III
STAT-NAT® EBV
STAT-NAT® EBV
754996f05e0fca7adb49bb4f55317226
III
STAT-NAT®HSV-1&2 FLEX
STAT-NAT®HSV-1&2 FLEX
330c3e127b7cf2aa64cf6958486b2c43
III
XPERT® HBV VIRAL LOAD
XPERT® HBV VIRAL LOAD
42f2035ea9d996370e525375c8167df7
III
1. STAT-NAT® BKV
1. NAT® BKV STATE
aace3ace1a8bf4b9c7138c8f42bcedf3
IIJun 11, 2034
1. SURESELECT CD GLASGOW CANCER PLUS
1. SURESELECT CD GLASGOW CANCER PLUS
35fe50dfc3d047a2f3c32d1760a98dcb
Jun 11, 2034
10. SURESELECT XT PRE-CAP
10. SURESELECT XT PRE-CAP
b7f4b9252ba65559414af433bc08fc7e
IJun 11, 2034
11. SURESELECT CANCER LUNG ASSAY PROBE, DNA
11. SURESELECT CANCER LUNG ASSAY PROBE, DNA
32f67f2f97750e9f0a15f9c7986e726d
IJun 11, 2034
12. SURESELECT CANCER COLON ASSAY PROBE, DNA
12. SURESELECT CANCER COLON ASSAY PROBE, DNA
375202e8c783744eaae3828814344add
IJun 11, 2034
13. SURESELECT CANCER PANCREAS ASSAY PROBE, DNA
13. SURESELECT CANCER PANCREAS ASSAY PROBE, DNA
8feac39a822f6845014bd7e737e99888
IJun 11, 2034
14. SURESELECT CANCER KIDNEY ASSAY PROBE, DNA
14. SURESELECT CANCER KIDNEY ASSAY PROBE, DNA
e48916e8c2ce5d4cccdcadfbd3f57647
IJun 11, 2034
15. SURESELECT CANCER BLADDER ASSAY PROBE, DNA
15. SURESELECT CANCER BLADDER ASSAY PROBE, DNA
33ba46ff47897a3ca0c5e52300a4ba6e
IJun 11, 2034
16. GENOMIC DNA REAGENTS
16. GENOMIC DNA REAGENTS
3dfb9bf7a61060df481757d740d1e176
IJun 11, 2034
2. SURESELECT CD GLASGOW CANCER PLUS, PC-POOL
2. SURESELECT CD GLASGOW CANCER PLUS, PC-POOL
de682d9c65015acb023b3a489bc2ebaa
IJun 11, 2034
3. SURESELECT XT HS HUMAN ALL EXON V8
3. SURESELECT XT HS HUMAN ALL EXON V8
8f48125d4e8e89b0e7678f8c1090021c
IJun 11, 2034
4. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8
4. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8
651877292fe3517b647133e664e2c54a
IJun 11, 2034
5. SURESELECT XT HS HUMAN ALL EXON V8+UTR
5. SURESELECT XT HS HUMAN ALL EXON V8+UTR
b0ca72921929327e11ede6c3331b0aaa
IJun 11, 2034
6. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8+UTR
6. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8+UTR
d9e3c7efacedc67c8b53ee62f7bfa397
IJun 11, 2034
7. SURESELECT XT HS HUMAN ALL EXON V8+NCV
7. SURESELECT XT HS HUMAN ALL EXON V8+NCV
4ce8d6583c81ff86490c41be1b42f27f
IJun 11, 2034
Risk class distribution
Devices by risk class
I
345
43.7% of total
II
244
30.9% of total
Unspecified
166
21.0% of total
III
23
2.9% of total
IIa
11
1.4% of total
About this profile
Explore comprehensive authorized company profile for ROCHEM BIOCARE COLOMBIA S.A.S. through Pure Global AI's free Colombia medical device database. This company manufactures 789 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Dec 20, 2021 to Jun 11, 2034.
This page provides detailed insights including recent registrations, risk class distribution (I: 345, Unspecified: 166, III: 23, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.